1. Home
  2. CRL
  3. CRL News

Latest Charles River Laboratories International Inc. (CRL) News on November 28, 2025

What Makes Charles River Laboratories (CRL) an Investment Bet?
CRL

Insider Monkey

4 days ago

What Makes Charles River Laboratories (CRL) an Investment Bet?

Does Charles River’s Lowered Guidance After a Strong Quarter Signal Shifting Priorities for CRL?
CRL

Simply Wall St.

6 days ago

Does Charles River’s Lowered Guidance After a Strong Quarter Signal Shifting Priorities for CRL?

Charles River Laboratories Stock: Is Wall Street Bullish or Bearish?
CRL

Barchart

7 days ago

Charles River Laboratories Stock: Is Wall Street Bullish or Bearish?

MA life sciences company Charles River Laboratories to lay off dozens of workers in 2026
CRL

Worcester Telegram & Gazette

8 days ago

MA life sciences company Charles River Laboratories to lay off dozens of workers in 2026

Charles River Labs (CRL): Assessing Valuation Following Recent Volatility and Share Price Recovery
CRL

Simply Wall St.

21 days ago

Charles River Labs (CRL): Assessing Valuation Following Recent Volatility and Share Price Recovery

CRL

Morningstar Research

22 days ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

22 days ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $200 From $195, Maintains Buy Rating

CRL

MT Newswires

22 days ago

JPMorgan Adjusts Price Target on Charles River Laboratories International to $165 From $160, Maintains Neutral Rating

CRL

MT Newswires

22 days ago

Barclays Adjusts Price Target on Charles River Laboratories International to $210 From $195, Maintains Overweight Rating

CRL

MT Newswires

22 days ago

Baird Upgrades Charles River Laboratories International to Outperform From Neutral, Adjusts PT to $199 From $178

CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook
CRL

StockStory

22 days ago

CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook

Charles River (CRL) Q3 2025 Earnings Transcript
CRL

Motley Fool

22 days ago

Charles River (CRL) Q3 2025 Earnings Transcript

CRL

MT Newswires

2 months ago

William Blair Upgrades Charles River Laboratories International to Outperform From Market Perform

Why Analysts Believe the Story for Charles River Labs Is Shifting After Recent Strategic Moves
CRL

Simply Wall St.

2 months ago

Why Analysts Believe the Story for Charles River Labs Is Shifting After Recent Strategic Moves

Charles River price target raised to $200 from $190 at Evercore ISI
CRL

TipRanks

2 months ago

Charles River price target raised to $200 from $190 at Evercore ISI

S&P 500 Stocks: These 5 Lead As Index Hits Record High
CRL

Investor's Business Daily

2 months ago

S&P 500 Stocks: These 5 Lead As Index Hits Record High

Charles River Laboratories (CRL) Stock Is Up, What You Need To Know
CRL

StockStory

2 months ago

Charles River Laboratories (CRL) Stock Is Up, What You Need To Know

CRL

MT Newswires

2 months ago

Evercore ISI Adjusts PT on Charles River Laboratories International to $200 From $190, Maintains Outperform Rating

CRL

MT Newswires

2 months ago

Charles River Labs Shares Rise After Barclays Upgrade

Why Charles River Laboratories (CRL) Stock Is Up Today
CRL

StockStory

2 months ago

Why Charles River Laboratories (CRL) Stock Is Up Today

Nike upgraded, RH downgraded: Wall Street's top analyst calls
CRL

The Fly

2 months ago

Nike upgraded, RH downgraded: Wall Street's top analyst calls

3 Reasons to Sell CRL and 1 Stock to Buy Instead
CRL

StockStory

5 months ago

3 Reasons to Sell CRL and 1 Stock to Buy Instead

3 Unpopular Stocks in Hot Water
CRL

StockStory

5 months ago

3 Unpopular Stocks in Hot Water

Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)
CRL

StockStory

5 months ago

Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)
CRL

StockStory

5 months ago

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
CRL

Business Wire

5 months ago

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

CRL

Argus Research

5 months ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

5 months ago

Market Update: BJ, CRL, PRGO, SPH

CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook
CRL

StockStory

6 months ago

CRL Q1 Earnings Call: Regulatory Changes and Market Stabilization Shape Outlook

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?
CRL

Zacks

6 months ago

Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?

1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of
CRL

StockStory

6 months ago

1 Safe-and-Steady Stock Worth Your Attention and 2 to Steer Clear Of

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers
CRL

StockStory

6 months ago

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best
CRL

StockStory

6 months ago

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best

Charles River Stock May Gain From Extended CHDI Research Deal on HD
CRL

Zacks

6 months ago

Charles River Stock May Gain From Extended CHDI Research Deal on HD

Charles River Laboratories to Present at William Blair and Jefferies Conferences
CRL

Business Wire

6 months ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
CRL

StockStory

6 months ago

1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
CRL

Insider Monkey

6 months ago

Charles River Laboratories International, Inc. (CRL): A Bull Case Theory

CRL

MT Newswires

6 months ago

Charles River Laboratories, CHDI Foundation Extend Collaboration

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
CRL

Business Wire

6 months ago

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT
CRL

Insider Monkey

6 months ago

Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT

CRL

MT Newswires

6 months ago

Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
CRL

StockStory

6 months ago

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know

Should You Continue to Hold Charles River Stock in Your Portfolio?
CRL

Zacks

6 months ago

Should You Continue to Hold Charles River Stock in Your Portfolio?

Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)
CRL

StockStory

6 months ago

Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)

CRL

MT Newswires

6 months ago

TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105

Understanding Charles River (CRL) Reliance on International Revenue
CRL

Zacks

6 months ago

Understanding Charles River (CRL) Reliance on International Revenue

Charles River Laboratories to Present at Bank of America Health Care Conference
CRL

Business Wire

7 months ago

Charles River Laboratories to Present at Bank of America Health Care Conference

Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow
CRL

StockStory

7 months ago

Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow

CRL

MT Newswires

7 months ago

Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot
CRL

BioPharma Dive

7 months ago

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

CRL

MT Newswires

7 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating

CRL

MT Newswires

7 months ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $180 From $140, Maintains Buy Rating

CRL

MT Newswires

7 months ago

UBS Cuts Price Target on Charles River Laboratories International to $150 From $185, Keeps Neutral Rating

CRL

MT Newswires

7 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating

CRL

MT Newswires

7 months ago

JPMorgan Adjusts Price Target on Charles River Laboratories International to $145 From $165, Maintains Neutral Rating

CRL

MT Newswires

7 months ago

Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
CRL

Simply Wall St.

7 months ago

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

CRL

MT Newswires

7 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating

CRL

MT Newswires

7 months ago

Charles River Laboratories Q1 Non-GAAP Earnings Rise, Revenue Falls

Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%
CRL

StockStory

7 months ago

Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates
CRL

Zacks

7 months ago

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

CRL

Associated Press Finance

7 months ago

Charles River: Q1 Earnings Snapshot

Charles River Laboratories Announces First-Quarter 2025 Results
CRL

Business Wire

7 months ago

Charles River Laboratories Announces First-Quarter 2025 Results

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
CRL

Business Wire

7 months ago

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect
CRL

StockStory

7 months ago

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

CRL

Morningstar Research

7 months ago

Analyst Report: Charles River Laboratories International, Inc.

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CRL

Zacks

7 months ago

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025
CRL

Insider Monkey

7 months ago

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
CRL

Zacks

7 months ago

Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
CRL

Business Wire

7 months ago

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

Here's How Charles River is Placed Just Ahead of Q1 Earnings
CRL

Zacks

7 months ago

Here's How Charles River is Placed Just Ahead of Q1 Earnings

3 Cash-Producing Stocks That Concern Us
CRL

StockStory

7 months ago

3 Cash-Producing Stocks That Concern Us

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break
CRL

Insider Monkey

7 months ago

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
CRL

Business Wire

7 months ago

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development

CRL

MT Newswires

7 months ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $100 From $169, Maintains Hold Rating

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
CRL

Insider Monkey

7 months ago

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

CRL

MT Newswires

7 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $118 From $101, Keeps Neutral Rating

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
CRL

Business Wire

7 months ago

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?
CRL

Zacks

7 months ago

Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?

CRL

MT Newswires

7 months ago

TD Cowen Adjusts Charles River Laboratories International's PT to $105 From $179, Keeps Hold Rating

CRL

MT Newswires

7 months ago

BofA Securities Cuts Charles River Laboratories International Price Target to $150 From $185

CRL

MT Newswires

8 months ago

Baird Adjusts PT on Charles River Laboratories International to $101 From $155, Keeps Neutral Rating

CRL

MT Newswires

8 months ago

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $140 From $210

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?
CRL

Insider Monkey

8 months ago

Why Charles River Laboratories International, Inc. (CRL) Went Down On Thursday?

CRL

Morningstar Research

8 months ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

8 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $145 From $160

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
CRL

Zacks

8 months ago

Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?
CRL

Zacks

8 months ago

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last?

CRL

MT Newswires

8 months ago

Evercore ISI Adjusts PT on Charles River Laboratories International to $135 From $175, Maintains In Line Rating

CRL

MT Newswires

8 months ago

Goldman Sachs Adjusts Charles River Laboratories International PT to $150 From $170, Maintains Neutral Rating

CRL

Morningstar Research

8 months ago

Analyst Report: Charles River Laboratories International, Inc.

CRL

MT Newswires

8 months ago

Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate
CRL

Zacks

8 months ago

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

CRL

MT Newswires

8 months ago

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
CRL

Business Wire

8 months ago

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now
CRL

Insider Monkey

8 months ago

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?
CRL

Zacks

8 months ago

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?

CRL

MT Newswires

8 months ago

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
CRL

StockStory

8 months ago

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

CRL

Argus Research

8 months ago

Analyst Report: Charles River Laboratories Int

Share on Social Networks: